| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/30/2023 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Common Stock | 21.2k | $0.00 | $0 | | 06/30/2023 |
| 06/30/2023 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Stock Option (right to buy) | 42.4k | $0.59 | $25k | | 06/30/2023 |
| 04/28/2023 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Restricted Stock Units | 8k | $0.00 | $0 | | 04/28/2023 |
| 04/28/2023 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Stock Option (Right to Buy) | 12.7k | $2.36 | $29.9k | | 04/28/2023 |
| 05/21/2022 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Restricted Stock Units | 9.3k | $0.00 | $0 | | 05/21/2022 |
| 05/21/2022 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Stock Option (Right to Buy) | 14.4k | $1.77 | $25.5k | | 05/21/2022 |
| 04/30/2022 | LEXICON PHARMACEUTICALS, INC. | LXRX | Exercise | Restricted Stock Units | 4k | $0.00 | $0 | | 04/30/2022 |
| 11/30/2021 | Cyclacel Pharmaceuticals, Inc. | CYCC | Sale | Common Stock | 12 | $3.57 | $42.9 | | 11/30/2021 |
| 08/24/2021 | Cyclacel Pharmaceuticals, Inc. | CYCC | Purchase | Common Stock | 1000 | $5.00 | $5k | | 08/24/2021 |
| 06/15/2021 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Stock Option (right to buy) | 4.7k | $6.69 | $31.8k | | 06/15/2021 |
| 06/15/2021 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Common Stock | 2.4k | $0.00 | $0 | | 06/15/2021 |
| 04/24/2021 | LEXICON PHARMACEUTICALS, INC. | LXRX | Exercise | Restricted Stock Units | 10.6k | $0.00 | $0 | | 04/24/2021 |
| 06/25/2020 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Stock Option (right to buy) | 5.2k | $4.70 | $24.4k | | 06/25/2020 |
| 04/26/2020 | LEXICON PHARMACEUTICALS, INC. | LXRX | Exercise | Restricted Stock Units | 3.5k | $0.00 | $0 | | 04/24/2020 |
| 04/24/2020 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Stock Option (Right to Buy) | 18.1k | $1.86 | $33.7k | | 04/24/2020 |
| 04/24/2020 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Restricted Stock Units | 10.6k | $0.00 | $0 | | 04/24/2020 |
| 05/29/2019 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Stock Option (right to buy) | 18.8k | $0.64 | $12k | | 05/29/2019 |
| 04/26/2019 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Stock Option (Right to Buy) | 6.5k | $5.67 | $37k | | 04/26/2019 |
| 04/26/2019 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Restricted Stock Units | 3.5k | $0.00 | $0 | | 04/26/2019 |
| 05/31/2018 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Stock Option (right to buy) | 8.6k | $1.42 | $12.2k | | 05/31/2018 |
| 04/27/2018 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Stock Option (Right to Buy) | 2.9k | $7.80 | $22.3k | | 04/27/2018 |
| 04/27/2018 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Common Stock | 2.6k | $0.00 | $0 | | 04/27/2018 |
| 05/30/2017 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Stock Option (right to buy) | 2k | $4.38 | $8.8k | | 05/30/2017 |
| 05/26/2016 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Option | 15k | $0.43 | $6.4k | | 05/26/2016 |
| 04/27/2012 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Common Stock | 11.8k | $0.00 | $0 | | 04/27/2012 |
| 04/27/2012 | LEXICON PHARMACEUTICALS, INC. | LXRX | Grant | Stock Option (Right to Buy) | 20k | $1.70 | $34k | | 04/27/2012 |